VittSphere ONE Calculators Blog CA Prabhakar Kumar · FCA · ICAI 560762
Case lawHigh Court › CIT v Glenmark Pharmaceuticals Ltd
High CourtHelps taxpayerValidity unconfirmeds.194Cs.201(1)s.201(1A)

CIT v Glenmark Pharmaceuticals Ltd

I get a third party to manufacture my products to my formulation and under my brand, but he buys the raw material himself. Should I be deducting tax under section 194C?

I get a third party to manufacture my products to my formulation and under my brand, but he buys the raw material himself. Should I be deducting tax under section 194C?

No, on those facts. The Bombay High Court held the contract was one of sale, not of work, so section 194C was not attracted and the company could not be treated as an assessee in default under section 201(1). What decides it is not the specifications or the trade mark but the material and the passing of property: the manufacturer sourced the raw material himself, worked at his own establishment on a principal to principal basis, and property passed only on delivery. The Court held clause (e) of the Explanation inserted by the Finance Act 2009 to be clarificatory of a position that had held the field for over three decades.

Decided by the High Court (High Court of Judicature at Bombay, Ordinary Original Civil Jurisdiction; Dr D.Y. Chandrachud and J.P. Devadhar, JJ (oral judgment by Dr D.Y. Chandrachud, J)) on 2010-03-12, reported as Income Tax Appeal No. 2256 of 2009 (Bombay High Court). It bears on section 194C, section 201(1), section 201(1A) of the Income Tax Act 1961, in TDS Defaults and How Tax Law Is Read matters.

Validity check could not be completed. No later history was checked and it is not known whether this judgment was carried to the Supreme Court. For periods from 1 October 2009 the point is in any event governed by clause (e) of the Explanation to section 194C as substituted by the Finance Act 2009, which the Court sets out; whether that clause has since been further amended was not verified from the material read.

Why it matters

This is the judgment practitioners reach for on outsourced or contract manufacture, and it does two things nothing else does as cleanly. First, it identifies the single operative test after Associated Cement had given work its widest meaning: not who wrote the specification or whose brand goes on the box, but whose material it is and when property passes. Specifications, an exclusivity covenant, a trade mark licence, a duty to surrender licences on termination - the Court held that none of these detracts from a sale, treating them as ordinary incidents of protecting a mark and the quality assurance the public is entitled to expect of a pharmaceutical product. Second, it settles the position for years before 1 October 2009 by holding clause (e) of the Explanation to be clarificatory and therefore retrospective, so that the pre-amendment years are governed by the same rule. It traces that rule through the Board's own circulars from 1972 onwards, which continued to except contracts of sale even after the 1994 circular widened section 194C to every kind of contract.

Binding within that High Court's jurisdiction. Persuasive elsewhere.

Not yet CA-verified. This entry was found through the sources listed under the Sources tab, and the summary reflects what those sources say. Nobody has yet read the full judgment and signed it off. Check the source before relying on it.

Read aloud by your device. Press again to stop.

Related

Other authorities on the same sections.